157 related articles for article (PubMed ID: 31620197)
1. Identification of prognostic biomarkers for malignant melanoma using microarray datasets.
Lin G; Yin G; Yan Y; Lin B
Oncol Lett; 2019 Nov; 18(5):5243-5254. PubMed ID: 31620197
[TBL] [Abstract][Full Text] [Related]
2. Identification of aberrantly methylated differentially expressed genes and pro-tumorigenic role of KIF2C in melanoma.
Huang CH; Han W; Wu YZ; Shen GL
Front Genet; 2022; 13():817656. PubMed ID: 35991567
[No Abstract] [Full Text] [Related]
3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
5. Identification of the interaction network of hub genes for melanoma treated with vemurafenib based on microarray data.
Quan L; Wang Y; Liang J; Shi J; Zhang Y; Tao K
Tumori; 2015; 101(4):368-74. PubMed ID: 25983087
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis.
Liao Y; Yin G; Wang X; Zhong P; Fan X; Huang C
Oncol Lett; 2019 Oct; 18(4):3723-3733. PubMed ID: 31516585
[TBL] [Abstract][Full Text] [Related]
7. Identification of key pathways and genes in nasopharyngeal carcinoma using bioinformatics analysis.
Zhu HM; Fei Q; Qian LX; Liu BL; He X; Yin L
Oncol Lett; 2019 May; 17(5):4683-4694. PubMed ID: 30988824
[TBL] [Abstract][Full Text] [Related]
8. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed genes, associated functional terms pathways, and candidate diagnostic biomarkers in inflammatory bowel diseases by bioinformatics analysis.
Cheng C; Hua J; Tan J; Qian W; Zhang L; Hou X
Exp Ther Med; 2019 Jul; 18(1):278-288. PubMed ID: 31258663
[TBL] [Abstract][Full Text] [Related]
10. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
11. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
Li L; Lei Q; Zhang S; Kong L; Qin B
Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
[TBL] [Abstract][Full Text] [Related]
12. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
Li G; Cai L; Zhou L
Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
[TBL] [Abstract][Full Text] [Related]
13. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
14. Identification of key candidate genes and pathways in endometrial cancer: Evidence from bioinformatics analysis.
Lv S; Xu X; Wu Z
Oncol Lett; 2019 Dec; 18(6):6679-6689. PubMed ID: 31807178
[TBL] [Abstract][Full Text] [Related]
15. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
Shang M; Zhang L; Chen X; Zheng S
Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
[TBL] [Abstract][Full Text] [Related]
16. Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis.
Man J; Zhang X; Dong H; Li S; Yu X; Meng L; Gu X; Yan H; Cui J; Lai Y
Oncol Lett; 2019 Nov; 18(5):5185-5196. PubMed ID: 31612029
[TBL] [Abstract][Full Text] [Related]
17. Identification of key biomarkers associated with development and prognosis in patients with ovarian carcinoma: evidence from bioinformatic analysis.
Shen J; Yu S; Sun X; Yin M; Fei J; Zhou J
J Ovarian Res; 2019 Nov; 12(1):110. PubMed ID: 31729978
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel biomarkers and candidate small-molecule drugs in cutaneous melanoma by comprehensive gene microarrays analysis.
Ma J; Cai X; Kang L; Chen S; Liu H
J Cancer; 2021; 12(5):1307-1317. PubMed ID: 33531976
[No Abstract] [Full Text] [Related]
19. AKT1 as the PageRank hub gene is associated with melanoma and its functional annotation is highly related to the estrogen signaling pathway that may regulate the growth of melanoma.
Zhao J; Zeng X; Song P; Wu X; Shi H
Oncol Rep; 2016 Oct; 36(4):2087-93. PubMed ID: 27573172
[TBL] [Abstract][Full Text] [Related]
20. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
Fang E; Zhang X
Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
